Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients

Journal of Addiction Medicine

Volumn 7, Issue 4, 2013, Pages 243-248

  Atkinson, Thomas S ^a   Sanders, Nichole ^a   Mancino, Michael ^a   Oliveto, Alison ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Clinical trial; Cocaine dependence; Disulfiram; Opioid dependence; QTc prolongation

Indexed keywords

DISULFIRAM; METHADONE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HUMAN; MALE; MEDICATION COMPLIANCE; OPIATE ADDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QTC INTERVAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALCOHOL DETERRENTS; COCAINE-RELATED DISORDERS; DISULFIRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS;

EID: 84887907732     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3182928e02     Document Type: Article

References (39)

1. Baker JA, Jatlow P, McCance-Katz EF. Disulfiram effects on responses to intravenous cocaine administration. Drug Alcohol Depend 2007;87(2/3):202-209.
2. Carroll KM, Fenton LR, Ball SA, et al. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebocontrolled trial. Arch Gen Psychiatry 2004;61(3):264-272.
3. Carroll KM, Rounsaville BJ, Bryant KJ. Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J Stud Alcohol 1993;54(2):199-208.
4. Chang K, Huang C, Liang H, et al. Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence. J Cardiovasc Electrophysiol 2012;23(5):527-533.
5. Charuvastra CV, Panell J, Hopper M, et al. The medical safety of the combined usage of disulfiram and methadone: pharmacological treatment for alcoholic heroin addicts. Arch Gen Psychiatry 1976;33:391-393.
6. Condelli WS, Fairbank JA, Dennis ML, et al. Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. J Subst Abuse Treat 1991;8(4):203-212.
7. Degenhardt L, Singleton J, Calabria B, et al. Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend 2011;113(2/3):88-95.
8. El-Bassel N, Gilbert L, Frye V, et al. Physical and sexual intimate partner violence among women in methadone maintenance treatment. Psychol Addict Behav 2004;18(2):180-183.
9. Erwin MB, Deliargyris EN. Cocaine-associated chest pain. Am J Med Sci 2002;324(1):37-44.
10. Fanoe S, Hvidt C, Ege P, et al. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart 2007;93(9):1051-1055.
11. Fareed A, Vayalapalli S, Byrd-Sellers J, et al. Onsite QTc interval screening for patients in methadone maintenance treatment. J Addict Dis 2010;29(1):15-22.
12. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV, Patient ed. Washington, DC: American Psychiatric Press; 1995.
13. Goldstein M, Anagnoste B, Lauber E, et al. Inhibition of dopamine-betahydroxylase by disulfiram. Life Sci 1964;3(7):763-767.
14. Grella CE, Anglin MD, Wugalter SE. Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients. Drug Alcohol Depend 1995;37(1):15-21.
15. Gupta A, Lawrence AT, Krishnan K, et al. Current conceptsinthe mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007;153(6):891-899.
16. Hameedi FA, Rosen MI, McCance-Katz EF, et al. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol Psychiatry 1995;37(8):560-563.
17. Hunt D, Spunt B, Lipton D, et al. The costly bonus: cocaine related crime among methadone treatment clients. Adv Alcohol Subst Abuse 1986;6(2):107-122.
18. Johnson BA. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Bioch Pharmacol 2008;75(1):34-56.
19. Kampman KM, Volpicelli JR, McGinnis DE, et al. Reliability and validity of the cocaine selective severity assessment. Addict Behav 1998;23(4):449-461.
20. Kautzner J. QT interval measurements. Cardiac Electrophysiol Rev 2002;6(3):273-277.
21. Krantz MJ, Lowery CM, Martell BA, et al. Effects of methadone on QT-interval dispersion. Pharmacotherapy 2005;25(11):1523-1529.
22. Levin KH, Copersino ML, Epstein D, et al. Longitudinal ECG changes in cocaine users during extended abstinence. Drug Alcohol Depend 2008;95(1/2):160-163.
23. Ling W, Weiss DG, Charuvastra VC, O'Brien CP. Use of disulfiram for alcoholics in methadone maintenance programs: a Veterans Administration Cooperative Study. Arch Gen Psychiatry 1983;40:851-854.
24. MacGowan RJ, Fichtner RR, Swanson N, et al. Factors associated with clientreported HIV infection among clients entering methadone treatment. AIDS Educ Prev 1997;9(3):205-217.
25. Magnano AR, Talathoti NB, Hallur R, et al. Effectof acute cocaine administration on the QTc interval of habitual users. Am J Cardiol 2006;97(8):1244-1246.
26. Maremmani I, Pacini M, Cesaroni C, et al. QTc interval prolongation in patients on long-term methadone maintenance therapy. Eur Addict Res 2005;11(1):44-49.
27. Martell BA, Arnsten JH, Krantz MJ, et al. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol 2005;95(7):915-918.
28. McLellan AT, Luborsky L, Woody GE. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis 1980;168(1):26-33.
29. Oliveto A, Chopra MP, Thostenson J, et al. Clinical Efficacy of Disulfiram at Higher Doses in Cocaine-Dependent Patients. Paper presented at the Annual Meeting of the College on Problems of Drug Dependence; June 9-14, 2012; Palm Springs, CA. Available at: http://www.cpdd.vcu.edu/Pages/Meetings/ CPDD12AbstractBook.pdf.
30. Oliveto A, Poling J, Mancino MJ, et al. Randomized, double blind, placebocontrolled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend 2011;113(2/3):184-191.
31. Petrakis IL, Carroll KM, Nich C, et al. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction 2000;95(2):219-228.
32. Reddy S, Hui D, El Osta B, et al. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med 2010;13(1):33-38.
33. Sawynok J. The therapeutic use of heroin-a review of the pharmacological literature. Can J Physiol Pharmacol 1986;64(1):1-6.
34. Schroeder JP, Cooper DA, Schank JR, et al. Disulfiram attenuates drugprimed reinstatement of cocaine seeking via inhibition of dopamine betahydroxylase. Neuropsychopharmacology 2010;35(12):2440-2449.
35. Sofuoglu M, Kosten T. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs 2006;11(1):91-98.
36. Tong TG, Benowitz NL, Kreek MJ. Methadone-disulfiram interaction during methadone-maintenance. J Clin Pharmacol 1980;20(8/9):506-513.
37. UNODC. World Drug Report 2010 (D. f. P. A. a. P. Affairs, Trans.). United Nations Office on Drugs and Crime; 2010.
38. Wallner C, Stöllberger C, Hlavin A, et al. Electrocardiographic abnormalities in opiate addicts. Addiction 2008;103:1987-1993.
39. Wei LJ, Lachin JM. Properties of the urn randomization in clinical trials. Control Clin Trials 1988;9(4):345-364.